Most Recent

image: Speaking of Science

Speaking of Science

By | November 1, 2013

November 2013's selection of notable quotes

2 Comments

image: 2013 Life Sciences Salary Survey

2013 Life Sciences Salary Survey

By | November 1, 2013

The Scientist opened up its annual Salary Survey to our international readers for the first time, revealing stark differences between average pay in the U.S., Europe, and the rest of the world.

9 Comments

image: Penetrating the Brain

Penetrating the Brain

By | November 1, 2013

Researchers use molecular keys, chisels, and crowbars to open the last great biochemical barricade in the body—the blood-brain barrier.

3 Comments

image: Evolving Pain Resistance

Evolving Pain Resistance

By | October 24, 2013

Grasshopper mice harbor mutations in a pain-transmitting sodium channel that allow them to prey on highly toxic bark scorpions.

2 Comments

image: FDA Considers Three-Parent IVF

FDA Considers Three-Parent IVF

By | October 17, 2013

The US regulatory agency will meet next week to discuss whether to allow human trials of a technique that combines the genetic information of three adults.

0 Comments

image: Opinion: Academic Waste

Opinion: Academic Waste

By | October 17, 2013

From funding to publishing, academic research needlessly burns through time and money.

3 Comments

image: Italian Stem Cell Trial Stopped

Italian Stem Cell Trial Stopped

By | October 11, 2013

With support from scientists, Italy’s health minister halts a controversial clinical trial.

1 Comment

image: Fighting Viruses with RNAi

Fighting Viruses with RNAi

By | October 10, 2013

The long-debated issue of whether mammals can use RNA interference as an antiviral defense mechanism is finally put to rest.

0 Comments

image: Mislabeled Microbes Cause Two Retractions

Mislabeled Microbes Cause Two Retractions

By | October 10, 2013

Two papers on plant immunity have been retracted, and questions remain about others with similar results. 

9 Comments

image: Geron’s Stem Cell Program Sold

Geron’s Stem Cell Program Sold

By | October 2, 2013

The company, which launched the first ever clinical trial for a human embryonic stem cell therapy before shuttering its stem cell arm, has finally struck a deal with BioTime.

0 Comments

Popular Now

  1. First In Vivo Function Found for Animal Circular RNA
  2. A Potential Remedy for the Aging Brain
    The Scientist A Potential Remedy for the Aging Brain

    In mice, injected fragments of a naturally occurring protein boost memory in young and old animals and improve cognition and mobility in a model of neurodegenerative disease. 

  3. Nature Index Identifies Top Contributors to Innovation
  4. Your Body Is Teeming with Weed Receptors
    Features Your Body Is Teeming with Weed Receptors

    And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.

AAAS